查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776864

末梢血單核細胞 (PBMC) 市場:產品·用途·技術·供給來源·各地區的機會及預測 (2018-2032年)

Peripheral Blood Mononuclear Cells Market Assessment, By Product, By Application, By Techniques, By Source, By Region, Opportunities, and Forecast, 2018-2032F
出版日期: | 出版商: Markets & Data | 英文 267 Pages | 商品交期: 3-5個工作天內

價格

全球週邊血單核細胞 (PBMC) 市場預計將從 2024 年的 3.3591 億美元成長至 2032 年的 7.2921 億美元，預測期內複合年增長率為 10.09%。

由於 PBMC 在免疫學、傳染病研究、血液學和藥物研發等眾多生物醫學研究領域中發揮重要作用，其需求正在顯著增長。這些多功能細胞，包括淋巴細胞和單核細胞，對於闡明疾病機制、評估治療藥物以及開發新型細胞療法至關重要。

隨著研究人員對細胞免疫學的理解日益加深，以及分離、凍存和培養技術的進步，週邊血液單一核細胞（PBMC）市場正在快速發展。全球慢性病和傳染病的增多，以及生物製藥研究的巨額投入，推動了對高品質週邊血單核細胞（PBMC）的需求。市場提供種類繁多的產品，包括凍結PBMC、新鮮PBMC以及專門的分離和活力評估試劑盒。密度梯度離心和白血球分離等新興技術提高了PBMC的純度和產量，進一步增強了其在複雜研究和臨床應用中的實用性。細胞檢測的日益普及以及個人化醫療的進步也推動了市場的成長。按地區劃分，北美憑藉其先進的研究基礎設施、大量的研發投入以及關鍵參與者的參與，引領市場。由於生技產業的崛起和醫療保健支出的不斷增長，亞太地區也有望迎來可觀的成長。 此外，PBMC 市場正在迎來一些主要參與者的加入，他們不僅提供細胞產品，還提供專業試劑和實驗室服務。生物技術的進步、生命科學領域資金的增加以及研究人員和臨床醫生知識的提升，預計將推動 PBMC 市場的持續成長。

本報告探討了全球週邊血單核細胞 (PBMC) 市場，並提供了市場定義和概述、市場規模趨勢和預測、各細分市場的詳細分析、案例研究、影響市場成長的因素分析、競爭格局以及主要公司的概況。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球末梢血單核細胞 (PBMC) 市場展望

  • 市場規模的分析·預測
  • 市場佔有率的分析·預測
    • 各產品
      • 凍存或冷凍PBMC
      • 培養或新鮮PBMC
      • PBMC分離與活力檢測試劑盒
    • 各用途
      • 免疫學
      • 血液學
      • 疫苗開發
      • 毒物學
      • 感染疾病
      • 其他
    • 各技術
      • 密度梯度離心
      • 白血球分離術（白血球分離）
      • 其他
    • 按來歷
      • 人
      • 動物
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東·非洲
    • 各企業市場佔有率分析(前五名公司以及其他)
  • 市場地圖分析

第5章 北美末梢血單核細胞 (PBMC) 市場展望

  • 市場規模的分析·預測
  • 市場佔有率的分析·預測
  • 各國市場評估
    • 加拿大
    • 墨西哥

第6章 亞太地區末梢血單核細胞 (PBMC) 市場展望

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼

第7章 歐洲末梢血單核細胞 (PBMC) 市場展望

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第8章 中東·非洲末梢血單核細胞 (PBMC) 市場展望

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第9章 南美末梢血單核細胞 (PBMC) 市場展望

  • 巴西
  • 阿根廷

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 大環境分析

第15章 價格分析

第16章 市場動態

  • 推動市場要素
  • 市場課題

第17章 法律規範

第18章 專利的形勢

第19章 案例研究

第20章 競爭情形

  • 前五名公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大企業的形勢
    • Lonza Group AG
    • Charles River Laboratories International, Inc.
    • Bio-Rad Laboratories Inc.
    • Corning Incorporated
    • Thermo Fisher Scientific Inc.
    • BioIVT LLC
    • Ixcells Biotechnologies USA, Inc.
    • Precision Medicine Group, LLC
    • Biopredic International
    • CGT Global LLC

第21章 策略性建議

第22章 關於調查公司·免責聲明

Product Code: MX10106

Global peripheral blood mononuclear cells (PBMC) market is projected to witness a CAGR of 10.09% during the forecast period 2025-2032, growing from USD 335.91 million in 2024 to USD 729.21 million in 2032. The demand for PBMCs is significantly rising as they are crucial for a wide range of applications in biomedical research, including immunology, infectious disease studies, hematology, and drug development. These versatile cells, which include lymphocytes and monocytes, are essential for understanding disease mechanisms, testing therapeutic agents, and developing novel cell-based treatments.

The PBMC market is developing rapidly as researchers better understand cellular immunology and as technological advancements improve isolation, cryopreservation, and culture techniques. The increasing global prevalence of chronic diseases and infectious diseases, coupled with significant investments in biopharmaceutical research, drives the demand for high-quality PBMCs. The market provides various products, including cryopreserved PBMCs, fresh PBMCs, and specialized isolation and viability kits. Modern techniques such as density gradient centrifugation and leukapheresis have improved the purity and yield of PBMC isolation, enhancing their utility in complex research and clinical applications. Market growth is further driven by the rising adoption of cell-based assays and the expansion of personalized medicine initiatives. The market leader, North America, holds regional dominance because of its advanced research infrastructure, significant R&D investments, and a strong presence of key market players, yet Asia-Pacific shows promising growth because of emerging biotechnology sectors and increasing healthcare expenditures.

Moreover, the PBMC market includes main industry players who provide extensive cell products alongside specialized reagents and laboratory services. PBMC market growth will persist in the future due to new biotechnological developments, increased funding for life sciences, and rising knowledge among researchers and clinicians. For instance, in October 2024, Lonza Group AG announced the expansion of its cell and gene therapy manufacturing facility in Houston, Texas, to meet the growing demand for advanced therapeutic products, which often rely on high-quality human cells like PBMCs for research and manufacturing.

Growing Demand in Immunotherapy and Vaccine Development Drives Market Share

The growing demand for peripheral blood mononuclear cells (PBMCs) in immunotherapy and vaccine development has significantly contributed to the increased market share of the PBMC market. PBMCs are indispensable for studying immune responses, developing cell-based therapies, and evaluating vaccine efficacy. The global rise in immune-mediated diseases, cancers, and the continuous threat of emerging infectious diseases has intensified research efforts into novel treatments. PBMCs provide a critical source of immune cells for understanding disease pathology and designing targeted interventions. The increasing number of clinical trials for immunotherapies, such as CAR T-cell therapy and checkpoint inhibitors, directly fuels the demand for precisely characterized and high-quality PBMCs. This has led to increased sales of specialized PBMC products and isolation kits. The PBMC market maintains strong market growth and has expanded its market share throughout the world due to their integral role in advancing these critical therapeutic areas.

For instance, in September 2024, Precision Medicine Group, LLC announced a new partnership with a leading biopharmaceutical company to provide comprehensive biomarker services, including the isolation and analysis of PBMCs, for their oncology clinical trials, highlighting the critical role of PBMCs in precision medicine.

Advancements in PBMC Isolation and Preservation Techniques Fuel Market Growth

The global peripheral blood mononuclear cells (PBMC) market experiences substantial expansion because of ongoing product innovations in PBMC isolation and preservation techniques. Modern methods, including advanced density gradient media, automated cell separation systems, and improved cryopreservation protocols, now provide better purity, viability, and recovery of PBMCs, leading to enhanced research outcomes and clinical applications. Healthcare providers and researchers use modern therapeutic agents, which consist of specialized cryopreservation solutions and viability reagents, to maintain cellular integrity and functionality, improving therapeutic results while decreasing cell loss during storage and transport. The integration of flow cytometry with molecular testing methods enables quick and exact characterization of PBMC subsets for various applications, which includes drug screening and disease monitoring. Modern technology allows PBMC-based research to deliver better results while simultaneously building greater confidence among researchers and clinicians about immediate treatment approaches. The growing availability of specialized PBMC products through biobanks and contract research organizations (CROs) helps expand market reach which further drives growth. The market will experience ongoing expansion across developed and emerging regions because innovation continues.

Additionally, to support the advancement in the PBMC market, regulatory bodies also take initiatives by standardizing collection and processing guidelines. For instance, in May 2025, the International Society for Cell & Gene Therapy (ISCT) released updated guidelines for the collection, processing, and cryopreservation of human cellular material, including PBMCs, to ensure consistency and quality for clinical research.

Cryopreserved or Frozen PBMC Holds the Largest Global Peripheral Blood Mononuclear Cells Market Share

The peripheral blood mononuclear cells market features Cryopreserved or Frozen PBMC as its leading market segment because researchers and clinicians highly value their long-term stability and convenience for longitudinal studies. These cells offer critical advantages, allowing for batch processing, retrospective analysis, and consistency across experiments, making them ideal for large-scale research projects and multi-center clinical trials. The increasing need for standardized, readily available cell sources for drug discovery, biomarker identification, and cell therapy development has significantly boosted the demand for cryopreserved PBMCs. Biobanks and commercial suppliers have expanded their offerings of well-characterized cryopreserved PBMC cohorts, ensuring reliable access for diverse research applications. The ability to store and transport these cells without compromising their viability or functionality has further solidified their dominance. Cryopreserved or Frozen PBMCs maintain the highest market share because of these combined market factors.

Additionally, to enhance the accessibility and quality of cryopreserved PBMCs, companies are expanding their bioprocessing capabilities and global distribution networks. For instance, in November 2024, BioIVT LLC announced the expansion of its human biospecimen collection and processing capabilities, specifically increasing its capacity for providing high-quality cryopreserved PBMCs for drug discovery and development.

North America Dominates the Global Peripheral Blood Mononuclear Cells Market Size

North America dominates the peripheral blood mononuclear cells (PBMC) market because of multiple essential elements. The region has several factors that make it the leading PBMC market. Significant research and development (R&D) investments exist at an elevated level throughout this region since academic institutions, pharmaceutical companies, and biotechnology firms show growing attention to advanced cellular research. These organizations now recognize the increasing utility of PBMCs in areas like personalized medicine, oncology, and infectious disease research, which drives their search for specialized PBMC products and services. Market growth receives substantial support from advanced biotechnology infrastructure and technological innovations. The establishment of major biopharmaceutical companies and well-funded research institutions enables quicker development of new PBMC isolation techniques, preservation methods, and cell-based assays. Market demand increases because researchers pursue cutting-edge therapies, while the prevalence of chronic diseases and the need for new drug targets become more common. Regulatory agencies, together with a growing number of skilled researchers and clinicians, work to increase the availability of services. The combination of these elements establishes North America as a leading force in the PBMC market which pushes forward both innovation and market expansion across the region.

Additionally, the growing funding for life sciences research in the United States also helps to dominate this region by increasing demand for high-quality PBMCs. For instance, in March 2025, according to the National Institutes of Health (NIH) funding data, total biomedical research funding increased by 7% compared to 2024, with a significant portion allocated to cell-based research and immunotherapy, directly benefiting the PBMC market.

Impact of Bioresearch Funding Cuts on Global Peripheral Blood Mononuclear Cells Market

Reductions in government and private funding for bioresearch can significantly impact the global peripheral blood mononuclear cells (PBMC) market. The initial impact of funding cuts causes a decrease in research grants and R&D budgets, which results in reduced purchasing power for academic institutions and biotechnology companies that rely heavily on PBMCs for their studies. This situation might limit the scope of ongoing research, delay new drug development, and impede the adoption of advanced cellular technologies. The slowdown in research activities could lead to a decline in demand for PBMC products, affecting suppliers and manufacturers. However, it might also force companies to innovate more cost-effective isolation and preservation methods or to seek alternative funding sources. The total market effect depends on the duration and severity of the funding cuts, together with the ability of market players to adapt to changing economic landscapes. The effects on scientific advancement and the market.

Key Players Landscape and Outlook

Continuous innovation characterized the landscape of the peripheral blood mononuclear cells market. Key players have established their strong presence in the PBMC market through strategic partnerships, collaboration, and acquisition and merger to lead the market. The future looks optimistic because growing demand from therapeutic and research applications, coupled with increasing investments in life sciences, creates steady market expansion.

In August 2024, Charles River Laboratories International, Inc. acquired a specialized cell therapy CRO, enhancing its capabilities in providing high-quality human PBMC services for preclinical and clinical research, expanding its offering in the cell and gene therapy space.

In July 2023, Thermo Fisher Scientific Inc. launched a new automated system for high-throughput isolation of PBMCs from blood samples, aiming to streamline laboratory workflows and improve the consistency and yield of isolated cells for various research applications.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Cryopreserved or Frozen PBMC
      • 4.2.1.2. Cultured or Fresh PBMC
      • 4.2.1.3. PBMC Isolation and Viability Kits
    • 4.2.2. By Application
      • 4.2.2.1. Immunology
      • 4.2.2.2. Hematology
      • 4.2.2.3. Vaccine Development
      • 4.2.2.4. Toxicology
      • 4.2.2.5. Infectious Disease
      • 4.2.2.6. Others
    • 4.2.3. By Techniques
      • 4.2.3.1. Density Gradient Centrifugation
      • 4.2.3.2. Leukapheresis
      • 4.2.3.3. Others
    • 4.2.4. By Source
      • 4.2.4.1. Human
      • 4.2.4.2. Animal
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product Type
    • 4.3.2. By Application
    • 4.3.3. By Techniques
    • 4.3.4. By Source
    • 4.3.5. By Region

5. North America Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Cryopreserved or Frozen PBMC
      • 5.2.1.2. Cultured or Fresh PBMC
      • 5.2.1.3. PBMC Isolation and Viability Kits
    • 5.2.2. By Application
      • 5.2.2.1. Immunology
      • 5.2.2.2. Hematology
      • 5.2.2.3. Vaccine Development
      • 5.2.2.4. Toxicology
      • 5.2.2.5. Infectious Disease
      • 5.2.2.6. Others
    • 5.2.3. By Techniques
      • 5.2.3.1. Density Gradient Centrifugation
      • 5.2.3.2. Leukapheresis
      • 5.2.3.3. Others
    • 5.2.4. By Source
      • 5.2.4.1. Human
      • 5.2.4.2. Animal
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Cryopreserved or Frozen PBMC
          • 5.3.1.2.1.2. Cultured or Fresh PBMC
          • 5.3.1.2.1.3. PBMC Isolation & Viability Kits
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Immunology
          • 5.3.1.2.2.2. Hematology
          • 5.3.1.2.2.3. Vaccine Development
          • 5.3.1.2.2.4. Toxicology
          • 5.3.1.2.2.5. Infectious Disease
          • 5.3.1.2.2.6. Others
        • 5.3.1.2.3. By Techniques
          • 5.3.1.2.3.1. Density Gradient Centrifugation
          • 5.3.1.2.3.2. Leukapheresis
          • 5.3.1.2.3.3. Others
        • 5.3.1.2.4. By Source
          • 5.3.1.2.4.1. Human
          • 5.3.1.2.4.2. Animal
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F

  • 6.1. India
  • 6.2. China
  • 6.3. Japan
  • 6.4. Australia
  • 6.5. Vietnam
  • 6.6. South Korea
  • 6.7. Indonesia

7. Europe Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Poland

8. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F

  • 8.1. Saudi Arabia
  • 8.2. UAE
  • 8.3. South Africa

9. South America Peripheral Blood Mononuclear Cells Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Regulatory Framework

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Lonza Group AG
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. Charles River Laboratories International, Inc.
    • 20.3.3. Bio-Rad Laboratories Inc.
    • 20.3.4. Corning Incorporated
    • 20.3.5. Thermo Fisher Scientific Inc.
    • 20.3.6. BioIVT LLC
    • 20.3.7. Ixcells Biotechnologies USA, Inc.
    • 20.3.8. Precision Medicine Group, LLC
    • 20.3.9. Biopredic International
    • 20.3.10. CGT Global LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1: Table 1: Top 10 Exporting Countries (Value), USD Thousand, 2020-2024
  • Table 2: Top 10 Importing Countries (Value), USD Thousand, 2020-2024
  • Table 3: Regulatory Compliance Framework for Peripheral Blood Mononuclear Cells (PBMCs)
  • Table 4: Globally R

List of Figures

  • Figure 1: Global Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 2: Global Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 3: Global Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 4: Global Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 5: Global Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 6: Global Peripheral Blood Mononuclear Cells Market Share, By Region, By Value, 2018-2032F
  • Figure 7: Global Peripheral Blood Mononuclear Cells Market Share, By Company, By Value, 2024
  • Figure 8: Global Peripheral Blood Mononuclear Cells Market Map, By Product, By Value, 2024
  • Figure 9: Global Peripheral Blood Mononuclear Cells Market Map, By Application, By Value, 2024
  • Figure 10: Global Peripheral Blood Mononuclear Cells Market Map, By Techniques, By Value, 2024
  • Figure 11: Global Peripheral Blood Mononuclear Cells Market Map, By Source, By Value, 2024
  • Figure 12: Global Peripheral Blood Mononuclear Cells Market Map, By Region, By Value, 2024
  • Figure 13: North America Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 14: North America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 15: North America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 16: North America Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 17: North America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 18: North America Peripheral Blood Mononuclear Cells Market Share, By Country, By Value, 2018-2032F
  • Figure 19: United States Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 20: United States Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 21: United States Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 22: United States Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 23: United States Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 24: Canada Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 25: Canada Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 26: Canada Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 27: Canada Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 28: Canada Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 29: Brazil Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 30: Brazil Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 31: Brazil Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 32: Brazil Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 33: Brazil Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 34: Europe Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 35: Europe Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 36: Europe Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 37: Europe Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 38: Europe Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 39: Europe Peripheral Blood Mononuclear Cells Market Share, By Country, By Value, 2018-2032F
  • Figure 40: Germany Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 41: Germany Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 42: Germany Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 43: Germany Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 44: Germany Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 45: France Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 46: France Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 47: France Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 48: France Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 49: France Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 50: United Kingdom Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 51: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 52: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 53: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 54: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 55: Italy Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 56: Italy Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 57: Italy Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 58: Italy Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 59: Italy Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 60: Spain Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 61: Spain Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 62: Spain Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 63: Spain Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 64: Spain Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 65: Russia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 66: Russia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 67: Russia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 68: Russia Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 69: Russia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 70: Poland Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 71: Poland Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 72: Poland Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 73: Poland Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 74: Poland Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 75: Netherlands Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 76: Netherlands Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 77: Netherlands Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 78: Netherlands Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 79: Netherlands Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 80: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 81: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 82: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 83: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 84: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 85: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Country, By Value, 2018-2032F
  • Figure 86: China Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 87: China Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 88: China Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 89: China Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 90: China Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 91: Japan Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 92: Japan Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 93: Japan Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 94: Japan Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 95: Japan Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 96: India Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 97: India Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 98: India Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 99: India Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 100: India Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 101: South Korea Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 102: South Korea Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 103: South Korea Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 104: South Korea Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 105: South Korea Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 106: Australia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 107: Australia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 108: Australia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 109: Australia Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 110: Australia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 111: Indonesia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 112: Indonesia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 113: Indonesia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 114: Indonesia Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 115: Indonesia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 116: Vietnam Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 117: Vietnam Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 118: Vietnam Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 119: Vietnam Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 120: Vietnam Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 121: Middle East & Africa Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 122: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 123: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 124: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 125: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 126: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Country, By Value, 2018-2032F
  • Figure 127: Saudi Arabia Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 128: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 129: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 130: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 131: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 132: UAE Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 133: UAE Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 134: UAE Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 135: UAE Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 136: UAE Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 137: South Africa Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 138: South Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 139: South Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 140: South Africa Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 141: South Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 142: South America Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 143: South America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 144: South America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 145: South America Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 146: South America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 147: South America Peripheral Blood Mononuclear Cells Market Share, By Country, By Value, 2018-2032F
  • Figure 148: Brazil Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 149: Brazil Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 150: Brazil Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 151: Brazil Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 152: Brazil Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F
  • Figure 153: Argentina Peripheral Blood Mononuclear Cells Market Size, By Value (USD Million), 2018-2032F
  • Figure 154: Argentina Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2018-2032F
  • Figure 155: Argentina Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2018-2032F
  • Figure 156: Argentina Peripheral Blood Mononuclear Cells Market Share, By Techniques, By Value, 2018-2032F
  • Figure 157: Argentina Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2018-2032F